Top DoD medicinal and botanical manufacturing contractors (NAICS 325411)
- Latest 12 months
- $2.8B
- Net obligations · Down $2.2B vs. $5.0B preceding
- Prime contractors
- 50
- With positive obligations in the latest 12 months
Research the DoD federal contracting market for medicinal and botanical manufacturing under NAICS 325411. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and observed contract vehicle usage.
Contract obligation trends for Medicinal and Botanical Manufacturing at the Department of Defense
Federal records show $18.9B in net obligations across 711,447 awards in Medicinal and Botanical Manufacturing at the Department of Defense from Oct 1, 2021 through Oct 23, 2026. This market accounts for 0.84% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 44.8% from $5.0B to $2.8B. 1 prime contractor accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY27 is year-to-date through Oct 23, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $3.4B | 176,168 | Complete |
| FY2023 | $3.3B | 166,232 | Complete |
| FY2024 | $4.2B | 173,217 | Complete |
| FY2025 | $5.0B | 120,738 | Complete |
| FY2026 | $3.1B | 76,338 | Complete |
Market at a glance
All reported prime contract awards- All-period net obligations
- $18.9B
- 711,447 awards · 97 prime contractors
- Latest 12-month movement
- −44.8%
- $2.8B vs. $5.0B
- Leading eight prime share
- 99.9%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.84% of $2.3T in agency-wide net obligations.
- Set-aside share when reported
- 1.6% of 1,704 awards with reported set-aside status.
- Set-aside reporting
- 27 set aside · 1,677 no set-aside · 709,743 not reported
What changed in the last 12 months?
Oct 24, 2025–Oct 23, 2026, compared with Oct 24, 2024–Oct 23, 2025.
Competitive shifts
Buyer demand
Reported obligations through DLA TROOP SUPPORT decreased
Reported obligations through DLA TROOP SUPPORT increased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Oct 23, 2026.
95.9% of positive obligations were attributed to DLA TROOP SUPPORT (SPE2D8). That represents $2.6B, down $2.2B from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- DLA TROOP SUPPORT (SPE2D8)95.9% · $2.6B · down $2.2B
- DLA TROOP SUPPORT (SPE2DR)2.9% · $78.5M · up $77.6M
- W6DZ CPE CBRND FT DETRICK0.78% · $21.5M · up $732K
- DLA TROOP SUPPORT (SPE2D3)0.18% · $4.9M · down $5.8M
- DLA TROOP SUPPORT (SPE2DU)0.17% · $4.7M · up $3.6M
- All other reported offices0.13% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
DLA TROOP SUPPORT (SPE2D8)
#1Rank unchangedLatest 12 months
$2.6B
95.9% of positive obligations
Versus preceding 12 months
−$2.2B
1 active prime contractor · 41,072 awards
View office comparison and evidence
Reported obligations decreased 45.2% from $4.8B to $2.6B. The office’s share of positive obligations moved from 96.6% to 95.9%, a change of −0.8 percentage points.
The latest period contains 41,072 actions across 41,072 awards. The preceding period contained 1 active prime contractor and 75,827 awards.
Leading award-level changes
- AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F1G47+$5.2M: $0 → $5.2M
- AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F0DPT+$4.9M: $0 → $4.9M
Reported funding office
DLA TROOP SUPPORT (SPE2DR)
#2Up 7 from #9Latest 12 months
$78.5M
2.9% of positive obligations
Versus preceding 12 months
+$77.6M
2 active prime contractors · 19,051 awards
View office comparison and evidence
Reported obligations increased 9385.6% from $827K to $78.5M. The office’s share of positive obligations moved from 0.020% to 2.9%, a change of +2.8 percentage points.
The latest period contains 19,051 actions across 19,051 awards. The preceding period contained 2 active prime contractors and 123 awards.
Leading award-level changes
- AMERISOURCEBERGEN DRUG CORP · PIID SPE2DR26FAWEP+$396K: $0 → $396K
- AMERISOURCEBERGEN DRUG CORP · PIID SPE2DR26FAXKF+$355K: $0 → $355K
Reported funding office
W6DZ CPE CBRND FT DETRICK
#3Rank unchangedLatest 12 months
$21.5M
0.78% of positive obligations
Versus preceding 12 months
+$732K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations increased 3.5% from $20.8M to $21.5M. The office’s share of positive obligations moved from 0.42% to 0.78%, a change of +0.4 percentage points.
The latest period contains 3 actions across 1 award. The preceding period contained 1 active prime contractor and 1 award.
Reported funding office
DLA TROOP SUPPORT (SPE2D3)
#4Rank unchangedLatest 12 months
$4.9M
0.18% of positive obligations
Versus preceding 12 months
−$5.8M
28 active prime contractors · 4,760 awards
View office comparison and evidence
Reported obligations decreased 54.3% from $10.6M to $4.9M. The office’s share of positive obligations moved from 0.21% to 0.18%, a change of 0.0 percentage points.
The latest period contains 4,760 actions across 4,760 awards. The preceding period contained 32 active prime contractors and 9,038 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2DU)
#5Up 1 from #6Latest 12 months
$4.7M
0.17% of positive obligations
Versus preceding 12 months
+$3.6M
3 active prime contractors · 2,711 awards
View office comparison and evidence
Reported obligations increased 355.5% from $1.0M to $4.7M. The office’s share of positive obligations moved from 0.020% to 0.17%, a change of +0.1 percentage points.
The latest period contains 2,711 actions across 2,711 awards and 1 newly active prime contractor. The preceding period contained 2 active prime contractors and 809 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2D0)
#6Down 1 from #5Latest 12 months
$1.9M
0.070% of positive obligations
Versus preceding 12 months
−$4.0M
20 active prime contractors · 189 awards
View office comparison and evidence
Reported obligations decreased 68.5% from $5.9M to $1.9M. The office’s share of positive obligations moved from 0.12% to 0.070%, a change of −0.1 percentage points.
The latest period contains 197 actions across 189 awards and 2 newly active prime contractors. The preceding period contained 31 active prime contractors and 303 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2DX)
#7Down 5 from #2Latest 12 months
$596K
0.020% of positive obligations
Versus preceding 12 months
−$125.3M
2 active prime contractors · 237 awards
View office comparison and evidence
Reported obligations decreased 99.5% from $125.9M to $596K. The office’s share of positive obligations moved from 2.5% to 0.020%, a change of −2.5 percentage points.
The latest period contains 237 actions across 237 awards. The preceding period contained 3 active prime contractors and 31,479 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2D2)
#8Up 3 from #11Latest 12 months
$551K
0.020% of positive obligations
Versus preceding 12 months
+$521K
1 active prime contractor · 2,187 awards
View office comparison and evidence
Reported obligations increased 1709.0% from $30K to $551K. The office’s share of positive obligations moved from 0% to 0.020%, a change of 0.0 percentage points.
The latest period contains 2,187 actions across 2,187 awards. The preceding period contained 1 active prime contractor and 22 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2DP)
#9Down 1 from #8Latest 12 months
$395K
0.010% of positive obligations
Versus preceding 12 months
−$478K
14 active prime contractors · 142 awards
View office comparison and evidence
Reported obligations decreased 54.8% from $874K to $395K. The office’s share of positive obligations moved from 0.020% to 0.010%, a change of 0.0 percentage points.
The latest period contains 143 actions across 142 awards and 3 newly active prime contractors. The preceding period contained 19 active prime contractors and 681 awards.
Reported funding office
AMC GORDON - PA
#10New to the positive-obligation rankingLatest 12 months
$351K
0.010% of positive obligations
Versus preceding 12 months
+$351K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations rose from $0 to $351K. The office’s share of positive obligations moved from 0% to 0.010%, a change of 0.0 percentage points.
The latest period contains 2 actions across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2DB)
#12Down 5 from #7Latest 12 months
$45K
0% of positive obligations
Versus preceding 12 months
−$906K
1 active prime contractor · 27 awards
View office comparison and evidence
Reported obligations decreased 95.3% from $951K to $45K. The office’s share of positive obligations moved from 0.020% to 0%, a change of 0.0 percentage points.
The latest period contains 27 actions across 27 awards. The preceding period contained 2 active prime contractors and 530 awards.
Reported funding office
WALTER REED ARMY INST OF RES - MM
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
+$1.7M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations moved from $1.7M in net deobligations to $0 in net obligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 3 active prime contractors and 3 awards.
Contract types, competition, and procurement methods
From Oct 24, 2025 through Oct 23, 2026, 69,905 awards had positive obligations totaling $2.8B. Negotiated Proposal/Quote was the leading reported procedure, accounting for 98.5% of positive obligations. Awards with a reported parent IDV accounted for 100.0%. Reported awards used contract vehicles such as Medical/Surgical CEC.
- Leading award type
- 100.0%
- Delivery Order
- Leading reported procedure
- 98.5%
- Negotiated Proposal/Quote
- Reported parent IDV
- 100.0%
- of positive obligations had a reported parent IDV
- Median reported offers
- 2
- 144 of 69,905 awards reported offers · Limited reporting
Observed contract vehicles
Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.
- Medical/Surgical CEC
$1.7M
0.060% of positive obligations · 1,382 matched awards
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 69,761 | $2.8B | 100.0% |
| Purchase Order(B) | 143 | $488K | 0.020% |
| Definitive Contract(D) | 1 | $351K | 0.010% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 69,761 | $2.8B | 100.0% |
| Not reported | 144 | $839K | 0.030% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 69,761 | $2.8B | 100.0% |
| Not reported | 144 | $839K | 0.030% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 68,471 | $2.7B | 98.5% |
| Only One Source(SSS) | 1 | $21.5M | 0.78% |
| Np(NEGOTIATED PROPOSAL/QUOTE) | 1,289 | $18.7M | 0.68% |
| Simplified Acquisition(SP1) | 139 | $830K | 0.030% |
| Sp1(SIMPLIFIED ACQUISITION) | 5 | $9K | 0% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full and Open Competition(A) | 68,471 | $2.7B | 98.5% |
| Not Available for Competition(B) | 1 | $21.5M | 0.78% |
| A(FULL AND OPEN COMPETITION) | 1,289 | $18.7M | 0.68% |
| Competed Under SAP(F) | 123 | $801K | 0.030% |
| Not Competed Under SAP(G) | 16 | $29K | 0% |
| F(COMPETED UNDER SAP) | 4 | $9K | 0% |
| Other reported values | 1 | $413 | <0.0001% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Not reported | 69,905 | $2.8B | 100.0% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 1 | $21.5M | 0.78% |
| SAP Non-Competition (FAR 13)(SP2) | 17 | $30K | 0% |
| Not reported | 69,887 | $2.7B | 99.2% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 68,500 | $2.7B | 99.3% |
| J(FIRM FIXED PRICE) | 1,293 | $18.7M | 0.68% |
| Fixed Price with Economic Price Adjustment(K) | 111 | $66K | 0% |
| K(FIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT) | 1 | $19 | 0% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Drugs and Biologicals(6505) | 62,310 | $2.7B | 98.2% |
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 7,556 | $49.6M | 1.8% |
| Household Furnishings(7210) | 2 | $20K | 0% |
| Surgical Dressing Materials(6510) | 27 | $18K | 0% |
| Hospital and Surgical Clothing and Related Special Purpose Items(6532) | 8 | $8K | 0% |
| Weapons Systems Specific Vehicular Accessories(2541) | 1 | $8K | 0% |
| Other reported values | 1 | $836 | <0.0001% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Defense Logistics Agency(97AS) | 69,902 | $2.7B | 99.2% |
| Department of the Army(2100) | 2 | $21.9M | 0.79% |
| Department of the Air Force(5700) | 1 | $85K | 0% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Dla Troop Support(SPE2D8) | 41,072 | $2.6B | 95.9% |
| Dla Troop Support(SPE2DR) | 18,859 | $78.5M | 2.9% |
| W6qk Acc-Apg(W911SR) | 1 | $21.5M | 0.78% |
| Dla Troop Support(SPE2D3) | 4,760 | $4.9M | 0.18% |
| Dla Troop Support(SPE2DU) | 2,711 | $4.7M | 0.17% |
| Dla Troop Support(SPE2D0) | 123 | $1.9M | 0.070% |
| Other reported values | 2,379 | $2.0M | 0.074% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SPE2DX22D0020(9700) | 7,195 | $579.3M | 21.0% |
| SPE2DX22D0089(9700) | 3,517 | $428.0M | 15.5% |
| SPE2DX22D0069(9700) | 3,075 | $395.8M | 14.3% |
| SPE2DX22D0049(9700) | 3,334 | $316.5M | 11.5% |
| SPE2DX22D0129(9700) | 2,825 | $292.9M | 10.6% |
| SPE2DX22D0029(9700) | 5,920 | $170.3M | 6.2% |
| SPE2DX22D0099(9700) | 2,061 | $133.3M | 4.8% |
| SPE2DX22D0010(9700) | 4,641 | $100.1M | 3.6% |
| Other reported values | 37,193 | $340.9M | 12.4% |
| Not reported | 144 | $839K | 0.030% |
Exact vehicle-match evidence
- Medical/Surgical CEC
1,382 awards · 8 matched parent PIIDs
Evidence: SPE2D017D0007, SPE2D018D0002, SPE2D019D0008, SPE2D020D0007, SPE2D020D0012, …
$1.7M · 0.060%
Reported award data linked 1,382 awards to a specific catalog vehicle.
Offers, award size, and timing
- Median reported offers
- 2 median
- 144 reported · 69,761 not reported · Limited reporting
- Positive award obligations
- $2K median
- $266–$18K middle 50%
- Reported performance period
- 1 day median
- 69,905 reported · 0 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 23, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 1 of 50prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 98.5%of positive obligations in the last 12 months
- Leading four prime contractors
- 99.8%of positive obligations in the last 12 months
- Leading eight prime contractors
- 99.9%of positive obligations in the last 12 months
Based on $2.8B in positive obligations during the 12 months ending Oct 23, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 24, 2024–Oct 23, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$2.7B
98.5%
Dollar movement
−$2.2B
vs. prior 12 months
Last 12mo awards
58,964 awards
58,964 actions
Historical and award details for AMERISOURCEBERGEN DRUG CORP
- Obligations: prior → latest
- $4.9B → $2.7B
- −45.0%
- Share: prior → latest
- 98.9% → 98.5%
- −0.4 percentage points
- All-period obligations
- $15.1B
- 79.9% of all-period positive obligations · 563,496 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 58,964 102,631 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$21.5M
0.78%
Dollar movement
+$732K
vs. prior 12 months
Last 12mo awards
1 award
3 actions
Historical and award details for EMERGENT BIODEFENSE OPERATIONS LANSING LLC
- Obligations: prior → latest
- $20.8M → $21.5M
- +3.5%
- Share: prior → latest
- 0.42% → 0.78%
- +0.4 percentage points
- All-period obligations
- $63.3M
- 0.33% of all-period positive obligations · 2 awards
- Recorded activity
- Since Jan 19, 2024
- through Mar 4, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1 1 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$8.7M
0.32%
Dollar movement
−$5.6M
vs. prior 12 months
Last 12mo awards
5,394 awards
5,394 actions
Historical and award details for DMS PHARMACEUTICAL GROUP INC
- Obligations: prior → latest
- $14.2M → $8.7M
- −39.0%
- Share: prior → latest
- 0.29% → 0.32%
- 0.0 percentage points
- All-period obligations
- $143.0M
- 0.76% of all-period positive obligations · 46,510 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 10 18 Not reported 5,384 5,353 Reported small business 5,393 5,371 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$3.6M
0.13%
Dollar movement
−$1.0M
vs. prior 12 months
Last 12mo awards
1,798 awards
1,798 actions
Historical and award details for CARDINAL HEALTH, INC.
- Obligations: prior → latest
- $4.7M → $3.6M
- −22.4%
- Share: prior → latest
- 0.090% → 0.13%
- 0.0 percentage points
- All-period obligations
- $25.1M
- 0.13% of all-period positive obligations · 11,408 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1,798 2,001 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$1.4M
0.050%
Dollar movement
−$971K
vs. prior 12 months
Last 12mo awards
573 awards
573 actions
Historical and award details for ATLANTIC DIVING SUPPLY, INC.
- Obligations: prior → latest
- $2.4M → $1.4M
- −40.3%
- Share: prior → latest
- 0.050% → 0.050%
- 0.0 percentage points
- All-period obligations
- $4.3M
- 0.020% of all-period positive obligations · 2,247 awards
- Recorded activity
- Since Apr 14, 2022
- through Apr 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 573 1,154 Reported small business 573 1,154 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$1.2M
0.040%
Dollar movement
−$190K
vs. prior 12 months
Last 12mo awards
550 awards
550 actions
Historical and award details for ALTITUDE TECHNOLOGIES INC.
- Obligations: prior → latest
- $1.4M → $1.2M
- −13.9%
- Share: prior → latest
- 0.030% → 0.040%
- 0.0 percentage points
- All-period obligations
- $3.4M
- 0.020% of all-period positive obligations · 2,366 awards
- Recorded activity
- Since Oct 1, 2021
- through May 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 550 860 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$820K
0.030%
Dollar movement
+$425K
vs. prior 12 months
Last 12mo awards
176 awards
176 actions
Historical and award details for CHARTWELL RX LLC
- Obligations: prior → latest
- $394K → $820K
- +107.9%
- Share: prior → latest
- 0.010% → 0.030%
- 0.0 percentage points
- All-period obligations
- $2.9M
- 0.020% of all-period positive obligations · 735 awards
- Recorded activity
- Since Oct 27, 2021
- through Apr 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 176 184 Reported small business 176 184 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$523K
0.020%
Dollar movement
−$935K
vs. prior 12 months
Last 12mo awards
544 awards
550 actions
Historical and award details for PHOENIX TEXTILE CORPORATION
- Obligations: prior → latest
- $1.5M → $523K
- −64.1%
- Share: prior → latest
- 0.030% → 0.020%
- 0.0 percentage points
- All-period obligations
- $8.7M
- 0.050% of all-period positive obligations · 6,225 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 544 1,128 Reported small business 126 182 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$464K
0.020%
Dollar movement
−$29K
vs. prior 12 months
Last 12mo awards
9 awards
9 actions
Historical and award details for CERA PRODUCTS, INC.
- Obligations: prior → latest
- $493K → $464K
- −5.9%
- Share: prior → latest
- 0.010% → 0.020%
- 0.0 percentage points
- All-period obligations
- $1.9M
- 0.010% of all-period positive obligations · 113 awards
- Recorded activity
- Since Jan 31, 2022
- through Apr 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 9 38 Reported small business 9 38 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$351K
0.010%
Dollar movement
−$83K
vs. prior 12 months
Last 12mo awards
1 award
2 actions
Historical and award details for CARDINAL HEALTH 414, LLC
- Obligations: prior → latest
- $434K → $351K
- −19.1%
- Share: prior → latest
- 0.010% → 0.010%
- 0.0 percentage points
- All-period obligations
- $1.8M
- 0.010% of all-period positive obligations · 1 award
- Recorded activity
- Since Nov 17, 2021
- through Mar 25, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$186K
0.010%
Dollar movement
−$125K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for EAGLE PHARMACEUTICALS, INC.
- Obligations: prior → latest
- $311K → $186K
- −40.3%
- Share: prior → latest
- 0.010% → 0.010%
- 0.0 percentage points
- All-period obligations
- $1.4M
- 0.010% of all-period positive obligations · 111 awards
- Recorded activity
- Since Oct 15, 2021
- through Feb 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1 20 Reported small business 1 20 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$180K
0.010%
Dollar movement
−$143K
vs. prior 12 months
Last 12mo awards
115 awards
115 actions
Historical and award details for COMBAT MEDICAL SYSTEMS LLC
- Obligations: prior → latest
- $324K → $180K
- −44.3%
- Share: prior → latest
- 0.010% → 0.010%
- 0.0 percentage points
- All-period obligations
- $2.3M
- 0.010% of all-period positive obligations · 2,054 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 115 115 Reported small business 115 115 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$151K
0.010%
Dollar movement
+$48K
vs. prior 12 months
Last 12mo awards
33 awards
33 actions
Historical and award details for SAGENT PHARMACEUTICALS, INC
- Obligations: prior → latest
- $103K → $151K
- +46.4%
- Share: prior → latest
- 0% → 0.010%
- 0.0 percentage points
- All-period obligations
- $1.2M
- 0.010% of all-period positive obligations · 164 awards
- Recorded activity
- Since Nov 19, 2021
- through Apr 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 33 33 Reported small business 33 33 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$149K
0.010%
Dollar movement
+$149K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for AMNEAL PHARMACEUTICALS OF NEW YORK, LLC
- Obligations: prior → latest
- $0 → $149K
- Not comparable
- Share: prior → latest
- 0% → 0.010%
- 0.0 percentage points
- All-period obligations
- $149K
- 0% of all-period positive obligations · 1 award
- Recorded activity
- Since Feb 11, 2026
- through Feb 11, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 0 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$125K
0%
Dollar movement
+$4K
vs. prior 12 months
Last 12mo awards
4 awards
4 actions
Historical and award details for BAYER HEALTHCARE PHARMACEUTICALS INC
- Obligations: prior → latest
- $121K → $125K
- +3.1%
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $653K
- 0% of all-period positive obligations · 56 awards
- Recorded activity
- Since Nov 15, 2021
- through Mar 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 4 4 Reported small business 0 0 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$5.2M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570863919!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.19% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $2.2B overall.
- Award net obligations
- $5.2M
- Share of 12-month positive obligations
- 0.19%
Supporting data
- Prime contractor
- #1 · 98.5% share
- $2.2B net decline despite this positive action
- Funding office
- #1 · 95.9% attributed share
- $2.2B net decline despite this positive action
This action
+$4.9M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570703411!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.18% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $2.2B overall.
- Award net obligations
- $4.9M
- Share of 12-month positive obligations
- 0.18%
Supporting data
- Prime contractor
- #1 · 98.5% share
- $2.2B net decline despite this positive action
- Funding office
- #1 · 95.9% attributed share
- $2.2B net decline despite this positive action
This action
+$4.8M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570863839!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.17% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $2.2B overall.
- Award net obligations
- $4.8M
- Share of 12-month positive obligations
- 0.17%
Supporting data
- Prime contractor
- #1 · 98.5% share
- $2.2B net decline despite this positive action
- Funding office
- #1 · 95.9% attributed share
- $2.2B net decline despite this positive action
This action
+$4.3M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570677280!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.16% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $2.2B overall.
- Award net obligations
- $4.3M
- Share of 12-month positive obligations
- 0.16%
Supporting data
- Prime contractor
- #1 · 98.5% share
- $2.2B net decline despite this positive action
- Funding office
- #1 · 95.9% attributed share
- $2.2B net decline despite this positive action
This action
+$4.2M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570703216!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.15% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $2.2B overall.
- Award net obligations
- $4.2M
- Share of 12-month positive obligations
- 0.15%
Supporting data
- Prime contractor
- #1 · 98.5% share
- $2.2B net decline despite this positive action
- Funding office
- #1 · 95.9% attributed share
- $2.2B net decline despite this positive action
This action
+$4.0M
AMERISOURCEBERGEN DRUG CORP
DLA TROOP SUPPORT
4570703403!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 0.15% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $2.2B overall.
- Award net obligations
- $4.0M
- Share of 12-month positive obligations
- 0.15%
Supporting data
- Prime contractor
- #1 · 98.5% share
- $2.2B net decline despite this positive action
- Funding office
- #1 · 95.9% attributed share
- $2.2B net decline despite this positive action
View recent award activity by date (10)
- Action+$21Award net obligations$21
- Action+$12Award net obligations$12
- Action+$3Award net obligations$3
- Action+$7KAward net obligations$7K
- Action+$3KAward net obligations$3K
- Action+$270Award net obligations$270
- Action+$2KAward net obligations$2K
- Action+$2KAward net obligations$2K
- Action+$343Award net obligations$343
- Action+$6KAward net obligations$6K
DoD medicinal and botanical manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top DoD medicinal and botanical manufacturing contractors?
In the 12 months through October 23, 2026, AMERISOURCEBERGEN DRUG CORP, EMERGENT BIODEFENSE OPERATIONS LANSING LLC, and DMS PHARMACEUTICAL GROUP INC were the leading DoD medicinal and botanical manufacturing prime contractors by positive obligations.
- #1
$2,717,216,385 in positive obligations
- #2
EMERGENT BIODEFENSE OPERATIONS LANSING LLC
$21,534,000 in positive obligations
- #3
$8,691,703 in positive obligations
Rankings use reported USAspending award data.
Did DoD contract obligations decrease in the medicinal and botanical manufacturing market?
Yes. Measured by net prime contract obligations, reported DoD activity in the medicinal and botanical manufacturing market decreased 44.8% from $4,993,252,524 in the preceding 12 months to $2,757,948,217 in the 12 months through October 23, 2026.
- Latest 12 months
- $2,757,948,217
- Net prime contract obligations
- Preceding 12 months
- $4,993,252,524
- Net prime contract obligations
- Change
- −44.8%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent DoD contract award activity was reported in the medicinal and botanical manufacturing market?
Recent DoD contract award activity reported in the medicinal and botanical manufacturing market included actions for AMERISOURCEBERGEN DRUG CORP during the 12 months through October 23, 2026.
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F1G47
Base award · February 18, 2026 · Action obligation: +$5,177,536
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F0DPT
Base award · February 3, 2026 · Action obligation: +$4,925,174
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F10Z9
Base award · February 18, 2026 · Action obligation: +$4,787,164
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F09G3
Base award · February 2, 2026 · Action obligation: +$4,342,424
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F1C24
Base award · February 3, 2026 · Action obligation: +$4,202,486
-
AMERISOURCEBERGEN DRUG CORP · PIID SPE2D826F09V0
Base award · February 3, 2026 · Action obligation: +$4,030,125
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for DoD contracts under NAICS 325411?
From October 24, 2025 through October 23, 2026, DoD reported 69,905 positive-obligation awards for medicinal and botanical manufacturing under NAICS 325411. The leading award type was delivery order. The leading reported procedure was negotiated proposal/quote.
- Positive-obligation awards
- 69,905
- Leading reported procedure
- Negotiated Proposal/Quote
- 98.5% of positive obligations
- Leading award type
- Delivery Order
- 100% of positive obligations
- Full and open
- 98.5%
- of positive obligations
- Reported parent IDV
- 100%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Leading-prime vehicle memberships:
Company memberships do not establish award-channel use.Reported obligations include contract actions from October 1, 2021 through October 23, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.
Review data methodology